QuidelOrtho

QuidelOrtho is a global diagnostics company formed by the 2022 merger of Quidel and Ortho Clinical Diagnostics, operating through Labs (clinical chemistry and immunoassay systems), Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The company serves hospitals, reference labs, blood banks, and retail clinics across North America, Europe, China, and Asia Pacific. Its Q2 2026 report showed constant-currency revenue growth of 2% to $631 million but a lowered full-year outlook and withdrawn free cash flow guidance amid continued China pressure and a softer respiratory testing environment, triggering a -24.7% single-day repricing.